Featured Article

Treating Osteoporotic Pain: Expert Interview

Treating Osteoporotic Pain: Expert Interview

Pain resulting from osteoporotic fractures should be treated with a multimodal approach that includes pharmacological and nonpharmacological strategies.

Latest News

Real-World Data Show Reduced Fracture Rates in Teriparatide-Treated Osteoporosis

Real-World Data Show Reduced Fracture Rates in Teriparatide-Treated Osteoporosis

Rates of incident clinical vertebral fracture, incident nonvertebral fracture, hip fracture, and clinical fractures decreased 6 months after initiation of teriparatide.

Genetic Screening May Predict Osteoporosis, Fracture Risk

Genetic Screening May Predict Osteoporosis, Fracture Risk

Genetic testing may identify individuals with an increased risk for osteoporosis and bone fracture.

One-Third of Canadian Patients Get Hip Fracture Repair Within 24 Hours

One-Third of Canadian Patients Get Hip Fracture Repair Within 24 Hours

Only one-third of Canadian patients received hip fracture repair surgery within the desired 24 hours.

HbA1c-Corrected FRAX Score May Better Predict Fracture Risk in Type 2 Diabetes

HbA1c-Corrected FRAX Score May Better Predict Fracture Risk in Type 2 Diabetes

A corrected HbA1c factor may improve the ability to predict the risk for fracture by the FRAX algorithm in T2D.

Decreased Osteoporosis Treatment Initiation Observed After Hip Fracture

Decreased Osteoporosis Treatment Initiation Observed After Hip Fracture

Researchers observed a reduction in subsequent nonvertebral fracture rates in patients who initiated osteoporosis treatment.

Effect of Mediterranean Diet Plus Vitamin D3 on Bone Density in Osteoporosis

Effect of Mediterranean Diet Plus Vitamin D3 on Bone Density in Osteoporosis

Investigators examined the effect of consuming a Mediterranean-style diet for 1 year on inflammatory response and bone health in the elderly.

Empagliflozin Does Not Increase Fracture Risk in Type 2 Diabetes

Empagliflozin Does Not Increase Fracture Risk in Type 2 Diabetes

The risk for bone fractures was not increased in patients with type 2 diabetes using empagliflozin compared with placebo or glimepiride.

New Romosozumab BLA Includes Data From Additional Osteoporosis Trials

New Romosozumab BLA Includes Data From Additional Osteoporosis Trials

The Biologics License Application has been resubmitted for Evenity, an investigational treatment for osteoporosis in postmenopausal women at high risk for fracture.

Romosozumab: Effective in Men With Osteoporosis

Romosozumab: Effective in Men With Osteoporosis

Romosozumab increased spine and hip bone mineral density after 12 months of treatment.

Osteoporosis Fracture Risk Awareness Lacking in Postmenopausal Women

Osteoporosis Fracture Risk Awareness Lacking in Postmenopausal Women

Postmenopausal women have little awareness of osteoporotic fracture risk and poor understanding that a fragility fracture may be indicative of osteoporosis and that it increases future fracture risk.

Sign Up for Free e-newsletters